Document is current

Any future updates will be listed below

Prognostic biomarkers to identify patients destined to develop severe Crohn’s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation

Crossref DOI link: https://doi.org/10.1186/s13643-016-0383-5

Published Online: 2016-12-01

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark